$5 billion Hong Kong IPO plan delayed? Sinopec does not comment.

Recently, there have been reports that the planned $5 billion Hong Kong IPO by Sinopharm might be postponed to wait for a overall recovery in the agriculture industry. Its advisory team believes that the likelihood of listing in 2027 is greater. Previously, there were rumors that the company planned to submit its listing application in June and hoped to complete the IPO within the year. On July 16, Interface News sought confirmation from Sinopharm, to which they responded by saying "we do not comment on market rumors" and reiterated that they will "return to the capital market when the time is right."